Pages that link to "Q34699946"
Jump to navigation
Jump to search
The following pages link to Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus (Q34699946):
Displaying 50 items.
- Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study (Q21135215) (← links)
- Endocrine fibroblast growth factors 15/19 and 21: from feast to famine (Q24629260) (← links)
- Fibroblast growth factor 21: from pharmacology to physiology (Q24658126) (← links)
- Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease (Q26991652) (← links)
- Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21 (Q28084197) (← links)
- Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology (Q28291993) (← links)
- Metformin stimulates FGF21 expression in primary hepatocytes. (Q29347106) (← links)
- ATF4- and CHOP-dependent induction of FGF21 through endoplasmic reticulum stress (Q33681667) (← links)
- Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues (Q33685319) (← links)
- FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue (Q33726498) (← links)
- Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile (Q33785827) (← links)
- Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis (Q34019712) (← links)
- Effects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus (Q34064416) (← links)
- Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARα and FGF21 transcripts in vivo (Q34215218) (← links)
- Serum FGF-21 levels in type 2 diabetic patients (Q34221475) (← links)
- Novel locus including FGF21 is associated with dietary macronutrient intake (Q34325630) (← links)
- Liraglutide increases FGF-21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance (Q34477327) (← links)
- Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIV (Q34637577) (← links)
- Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis. (Q34674492) (← links)
- Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females (Q34899333) (← links)
- A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice (Q34914262) (← links)
- Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta). (Q35222785) (← links)
- Fibroblast growth factor 21: a novel metabolic regulator (Q35770027) (← links)
- Various oscillation patterns of serum fibroblast growth factor 21 concentrations in healthy volunteers (Q35770034) (← links)
- FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis (Q35986135) (← links)
- Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis (Q36188382) (← links)
- Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21 (Q36674741) (← links)
- Klotho, FGF21 and FGF23: Novel Pathways to Musculoskeletal Health? (Q36864419) (← links)
- Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease (Q36889026) (← links)
- The FGF family: biology, pathophysiology and therapy (Q36933339) (← links)
- Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage (Q36982020) (← links)
- Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health. (Q37108770) (← links)
- Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. (Q37236253) (← links)
- Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia). (Q37298610) (← links)
- Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity (Q37328872) (← links)
- Anti-human fibroblast growth factor-21 monoclonal antibody preparation, characterization and analysis of in vitro bioactivity (Q37406671) (← links)
- Elevated serum fibroblast growth factor 21 levels correlate with immune recovery but not mitochondrial dysfunction in HIV infection (Q37418033) (← links)
- Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia (Q37429196) (← links)
- Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice (Q37550329) (← links)
- Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates (Q37571417) (← links)
- Biomarker qualification via public-private partnerships (Q37658269) (← links)
- Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease (Q37781747) (← links)
- Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology (Q38077471) (← links)
- Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents (Q38216640) (← links)
- The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target (Q38235454) (← links)
- Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status (Q38454611) (← links)
- FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes (Q38645276) (← links)
- Fibroblast growth factor 21: a regulator of metabolic disease and health span (Q38755577) (← links)
- Fibroblast growth factor 21 night watch: advances and uncertainties in the field (Q39017842) (← links)
- Epicardial fat, body mass index, and triglyceride are independent contributors of serum fibroblast growth factor 21 level in obese premenopausal women (Q39113702) (← links)